Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Kymera Therapeutics, Inc. 401(K) Profit Sharing Plan Trust is a benefit plan reported by Kymera Therapeutics, Inc. under EIN 81-2992166 and plan number 001. The latest loaded filing year is 2023. The filing reports 195 participants and $18,409,012 in end-of-year plan assets, where available in the loaded dataset.
Reported financial statement (2023 · Schedule H)
Net assets
- Total assets (EOY)
- $18,409,012
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $18,409,012
- Net assets (BOY)
- $9,575,454
Income & contributions
- Employer contributions
- $1,773,456
- Participant contributions
- $3,254,908
- Total contributions
- $6,978,901
- Total income / additions
- $9,469,527
Expenses & distributions
- Benefits paid
- $594,966
- Administrative expenses
- $41,003
- Total expenses
- $635,969
- Net increase / (decrease)
- $8,833,558